DAP3 and breast carcinoma: Silencing of DAP3 leaded to the promoted tumor progression including the enhanced adhesion, migration and invasion in breast cancer cells. HSP90 and DAP3 expression patterns in breast cancer are comparable. Breast cancer metastasis and local recurrence are linked to decreased expression of HSP90.